Drug Information
Drug (ID: DG01580) and It's Reported Resistant Information
Name |
MPI-0479605
|
||||
---|---|---|---|---|---|
Synonyms |
MPI-0479605; 1246529-32-7; N6-Cyclohexyl-N2-(2-methyl-4-morpholinophenyl)-9H-purine-2,6-diamine; CHEMBL2047943; MPI0479605; MPI 0479605; 6-N-cyclohexyl-2-N-(2-methyl-4-morpholin-4-ylphenyl)-7H-purine-2,6-diamine; C22H29N7O; WITJ0018D; MPI-0479605 hydrochloride; GTPL9399; SCHEMBL2946927; US11208696, Example 1; BDBM532282; HMS3653P07; HMS3740O21; BCP27897; EX-A1092; WZB52932; 2574AH; BDBM50386816; MFCD28099811; ZINC68246140; AKOS026750424; AKOS027289040; CCG-268735; CS-4665; SB19447; NCGC00386327-02; NCGC00386327-03; AC-33011; DA-46740; HY-12660; B3706; FT-0699832; S7488; SW220076-1; A14290; n6-cyclohexyl-n2-(2-methyl-4-morpholino-phenyl)-9h-purine-2,6-diamine; N~-6~-cyclohexyl-N~2~-[2-methyl-4-(morpholin-4-yl)phenyl]-9H-purine-2,6-diamine; 9H- Purine- 2, 6- diamine, N6- cyclohexyl- N2- [2- methyl- 4- (4- morpholinyl) phenyl] -
Click to Show/Hide
|
||||
Structure | |||||
Target | . | NOUNIPROTAC | [1] | ||
Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
Formula |
5
|
||||
IsoSMILES |
CC1=C(C=CC(=C1)N2CCOCC2)NC3=NC4=C(C(=N3)NC5CCCCC5)NC=N4
|
||||
InChI |
InChI=1S/C22H29N7O/c1-15-13-17(29-9-11-30-12-10-29)7-8-18(15)26-22-27-20-19(23-14-24-20)21(28-22)25-16-5-3-2-4-6-16/h7-8,13-14,16H,2-6,9-12H2,1H3,(H3,23,24,25,26,27,28)
|
||||
InChIKey |
OVJBNYKNHXJGSA-UHFFFAOYSA-N
|
||||
PubChem CID |
Type(s) of Resistant Mechanism of This Drug
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Colon cancer [ICD-11: 2B90]
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Catenin beta-1 (CTNNB1) | [1] | |||
Molecule Alteration | IF-deletion | p.S45delS (c.133_135delTCT) |
||
Sensitive Disease | Colon cancer [ICD-11: 2B90.1] | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 |
SW48 cells | Colon | Homo sapiens (Human) | CVCL_1724 | |
TOV-21G cells | Ovary | Homo sapiens (Human) | CVCL_3613 | |
HuTu80 cells | Small intestine | Homo sapiens (Human) | CVCL_1301 | |
TOV-112D cells | Ovary | Homo sapiens (Human) | CVCL_3612 | |
LS 174T cells | Colon | Homo sapiens (Human) | CVCL_1384 | |
A427 cells | Lung | Homo sapiens (Human) | CVCL_1055 | |
In Vivo Model | Mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Gene set analysis | |||
Experiment for Drug Resistance |
Cell proliferation assay | |||
Mechanism Description | The if-deletion p.S45delS (c.133_135delTCT) in gene CTNNB1 cause the sensitivity of MPI-0479605 by unusual activation of pro-survival pathway. |
Colorectal cancer [ICD-11: 2B91]
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Catenin beta-1 (CTNNB1) | [1] | |||
Molecule Alteration | Missense mutation | p.S45F (c.134C>T) |
||
Sensitive Disease | Colorectal cancer [ICD-11: 2B91.1] | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 |
SW48 cells | Colon | Homo sapiens (Human) | CVCL_1724 | |
TOV-21G cells | Ovary | Homo sapiens (Human) | CVCL_3613 | |
HuTu80 cells | Small intestine | Homo sapiens (Human) | CVCL_1301 | |
TOV-112D cells | Ovary | Homo sapiens (Human) | CVCL_3612 | |
LS 174T cells | Colon | Homo sapiens (Human) | CVCL_1384 | |
A427 cells | Lung | Homo sapiens (Human) | CVCL_1055 | |
In Vivo Model | Mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Gene set analysis | |||
Experiment for Drug Resistance |
Cell proliferation assay | |||
Mechanism Description | The missense mutation p.S45F (c.134C>T) in gene CTNNB1 cause the sensitivity of MPI-0479605 by unusual activation of pro-survival pathway | |||
Key Molecule: Catenin beta-1 (CTNNB1) | [1] | |||
Molecule Alteration | Missense mutation | p.S33Y (c.98C>A) |
||
Sensitive Disease | Colorectal cancer [ICD-11: 2B91.1] | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 |
SW48 cells | Colon | Homo sapiens (Human) | CVCL_1724 | |
TOV-21G cells | Ovary | Homo sapiens (Human) | CVCL_3613 | |
HuTu80 cells | Small intestine | Homo sapiens (Human) | CVCL_1301 | |
TOV-112D cells | Ovary | Homo sapiens (Human) | CVCL_3612 | |
LS 174T cells | Colon | Homo sapiens (Human) | CVCL_1384 | |
A427 cells | Lung | Homo sapiens (Human) | CVCL_1055 | |
In Vivo Model | Mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Gene set analysis | |||
Experiment for Drug Resistance |
Cell proliferation assay | |||
Mechanism Description | The missense mutation p.S33Y (c.98C>A) in gene CTNNB1 cause the sensitivity of MPI-0479605 by unusual activation of pro-survival pathway |
Lung cancer [ICD-11: 2C25]
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Catenin beta-1 (CTNNB1) | [1] | |||
Molecule Alteration | Missense mutation | p.T41A (c.121A>G) |
||
Sensitive Disease | Lung adenocarcinoma [ICD-11: 2C25.0] | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | HCT116 cells | Colon | Homo sapiens (Human) | CVCL_0291 |
SW48 cells | Colon | Homo sapiens (Human) | CVCL_1724 | |
TOV-21G cells | Ovary | Homo sapiens (Human) | CVCL_3613 | |
HuTu80 cells | Small intestine | Homo sapiens (Human) | CVCL_1301 | |
TOV-112D cells | Ovary | Homo sapiens (Human) | CVCL_3612 | |
LS 174T cells | Colon | Homo sapiens (Human) | CVCL_1384 | |
A427 cells | Lung | Homo sapiens (Human) | CVCL_1055 | |
In Vivo Model | Mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Gene set analysis | |||
Experiment for Drug Resistance |
Cell proliferation assay | |||
Mechanism Description | The missense mutation p.T41A (c.121A>G) in gene CTNNB1 cause the sensitivity of MPI-0479605 by unusual activation of pro-survival pathway |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.